Fyteko
Fyteko is a Belgian agtech company that develops bio-based plant biostimulants using proprietary hydroxycinnamic acid oligomer Signal Molecule technology, selling through regional distributors to row crop and specialty crop farmers in Europe and Latin America to enhance drought and heat resilience.
- Company typePrivate
- Founded2014
- HeadquartersBrussels, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Fyteko does
Fyteko is a Belgian agtech company founded in 2014 that develops and commercializes bio-based plant biostimulants and biocontrol products. The company's proprietary technology platform is centered on Signal Molecules based on hydroxycinnamic acid oligomers, single chemically well-defined active ingredients produced via green chemistry (biocatalysis without organic solvents). These molecules act as plant signaling compounds that activate the plant's internal tolerance mechanisms against abiotic stresses such as drought and heat, as opposed to the complex mixtures (amino acids, seaweed extracts, humic acids) that dominate the broader biostimulant category.
Fyteko's commercial product portfolio includes two core lines: NURSPRAY® (foliar spray biostimulant, with HC and standard variants) and NURSEED® (seed treatment, with HC and MAX variants for row crops and vegetables). VacStress® is a single-molecule, signal-based biostimulant applied in-furrow, launched in Brazil. The company is also developing a pipeline of herbicide bioenhancers (enabling 30–50% dose reduction of conventional herbicides) and next-generation biopesticides targeting antimicrobial activity and plant defense activation. The technology is protected by six patent families, validated across 800+ trials, and applied on 500,000+ hectares in 2024/25.
Fyteko generates revenue through B2B product sales distributed via a channel partner model, with 10+ regional distribution partners covering Western Europe, Central/Eastern Europe (Austria, Hungary, Romania), and Latin America (Brazil, Chile, Peru, Colombia, Ecuador). The company's EU sales launch occurred in 2023 following product registrations obtained in 2018–2019. End customers are primarily row crop farmers (corn, soybean, wheat, sunflower, oilseed rape) and specialty crop producers (cherries, table grapes, apples, vegetables). The company employs 20+ experts across R&D, regulatory, production, and commercial functions, and operates a 750 m² production facility in Mons, Belgium, alongside offices in Brussels and Louvain-la-Neuve. A €13 million Series B was raised in February 2025 to fund global scale-up.
Fyteko firmographics
Firmographics- Name
- Fyteko
- Legal name
- SA Fyteko
- Website
- https://fyteko.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Fyteko is a Belgian agtech company that develops bio-based plant biostimulants using proprietary hydroxycinnamic acid oligomer Signal Molecule technology, selling through regional distributors to row crop and specialty crop farmers in Europe and Latin America to enhance drought and heat resilience.
- Ownership category
- akta.pro rank
Fyteko industry classification
Industry- Product category
- Agricultural Biostimulants
- NAICS
- Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253), Pesticide and Other Agricultural Chemical Manufacturing (325320), Pesticide and Other Agricultural Chemical Manufacturing (32532)
- SIC
- Agricultural Chemicals (2870), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Biostimulants & Plant Health Biologicals (Microbial/Non-microbial) (AFABAEAK)
- akta.pro secondary industries
- Seed Inoculants & Biological Seed Enhancers (Rhizobia, Mycorrhizae, PGPR) (AFABAFAJ), Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM), Biostimulant-Enhanced Fertilizers (Humic/Fulvic, Amino Acids, Seaweed Blends) (AFABACAK)
Keywords
Where Fyteko is headquartered
LocationHeadquarters
- HQ city
- Brussels
- HQ country
- Belgium
- HQ region
- Europe
Offices3 records
Markets served
Fyteko business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Biostimulant Products: Fyteko generates revenue through the sale of biostimulant products including NURSPRAY® (foliar spray) and NURSEED® (seed treatment). Products are sold through distribution partners in multiple geographies including Europe and Latin America.
- Herbicide Bioenhancers (Pipeline): Future revenue stream from herbicide bioenhancer products that allow dose reduction of conventional herbicides.
- Biopesticides (Pipeline): Future revenue stream from biopesticide products currently in R&D phase, targeting plant pathogen protection.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels4 records
Fyteko product offering
Product offeringCore offering
Fyteko develops, manufactures, and commercializes bio-based plant biostimulants built on a proprietary Signal Molecule technology platform using hydroxycinnamic acid oligomers. Its commercial product lines comprise NURSPRAY® foliar spray biostimulants and NURSEED® seed treatment biostimulants, with VacStress® for furrow application, designed to enhance crop resilience against abiotic stresses such as drought and heat and improve yields through sustainable mechanisms.
Product overview
Fyteko offers a portfolio of bio-based biostimulant products for sustainable agriculture, centered on its proprietary Signal Molecule technology (hydroxycinnamic acid oligomers). The commercial portfolio comprises two core product lines: NURSPRAY® (foliar spray biostimulant) available in standard and HC formulations, and NURSEED® (seed treatment biostimulant) available in HC and MAX variants for different crop types. The company is also bringing VacStress® to market in Brazil through partnerships. A development pipeline includes herbicide bioenhancers and next-generation biopesticides. All products are designed to enhance crop resilience to abiotic stress (drought, heat) and improve yields through sustainable, bio-based mechanisms.
Differentiator
Problem solved
Functional benefit
Brands
- NURSEED®: Seed treatment biostimulant formulation with novel Signal Molecule (hydroxycinnamic acid oligomers) that enhances crop establishment and mitigates effects of abiotic stress such as drought or heat.
- NURSPRAY®
- VacStress®
Products and services
- NURSPRAY® Foliar spray biostimulant featuring a novel Signal Molecule (hydroxycinnamic acid oligomers) that boosts crop resilience and recovery under abiotic stress conditions such as drought or heat. Activates plants' internal tolerance mechanisms and enhances presence of natural osmoprotectants in crops. For row crop farmers (corn, soybean, wheat) and specialty crop producers.
- NURSPRAY®HC Concentrated SL formulation of NURSPRAY® for foliar application at 0.2 L/ha/application depending on dilution volume. Designed for specialty crops including cherries, table grapes, apples, and other high-value produce.
- NURSEED® Seed treatment biostimulant with novel Signal Molecule based on hydroxycinnamic acid oligomers. Enhances crop establishment and mitigates effects of abiotic stress such as drought or heat by improving emergence, vigour, and uniformity, strengthening seedlings in early development stages.
- NURSEED®HC Row crop formulation of NURSEED® at 1-6 mL/kg of seeds concentration. Designed for row crops including corn, soybean, sunflower, and oilseed rape.
- NURSEED®MAX Vegetable seeds formulation of NURSEED® at 10-12 mL/kg of seeds concentration. Designed for vegetable seeds requiring higher application rates.
- VacStress® Single molecule, signal-based biostimulant applied in furrow to support stronger early crop development and better tolerance to abiotic stress such as drought and heat. Shows yield gains of up to 10% in early field trials on soybean and corn in Brazil.
- Herbicide Bioenhancers Hydroxycinnamic polymer technology in development that functions as an herbicide enhancer, allowing herbicide doses to be reduced by 30-50% without compromising efficacy. Improves herbicide retention on leaf and enhances cuticle penetration.
- Biopesticides Next-generation biopesticide candidates in research and development phase. Biomolecule-based alternatives that can trigger plant innate immunity, silence harmful genes, or directly inhibit pathogens by disrupting membranes and cell walls.
Quantifiable outcome
- Up to 10% yield boost with NURSPRAY® in field conditions with 80%+ success rate
- +4 more outcomes
Companies that use Fyteko
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
Fyteko technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Fyteko partnerships and signals
Strategic signalPartnerships
19 partnerships are on record, tiered core, major and supporting.
- Point GroupcoreExpansion of partnership with Point Group to Colombia and Ecuador, building on successful launch in Peru. NURSPRAY®HC commercialized under TRUST® brand. Initial applications in ornamentals, tomatoes, and potatoes with expansion planned.
- AnasaccoreStrategic distribution agreement for NURSPRAY®HC in Chile. Anasac is one of Chile's leading agricultural input companies with 78+ years of market presence. Initial targets: cherries, table grapes, and apples with expansion planned to additional specialty crops.
- AgrilifecoreStrategic partnership with Agrilife (part of Grupo Casa Bugre, Brazil) to scale VacStress® biostimulant in Brazil. Early field results on soybean and corn show yield gains up to 10%. Partnership leverages Agrilife's extensive technical expertise and nationwide commercial network.
- Kwizda Agro Hungary KftcoreExclusive distribution agreement for NURSPRAY®HC in Austria, Hungary, and Romania. Kwizda Agro is a key player in Europe's crop protection distribution structure, providing access to thousands of hectares of arable and specialty crops.
- Horizon 2020 / European CommissionmajorParticipated in Horizon 2020, the largest EU Research and Innovation programme. Grant funded two-year R&D project beginning May 2020 covering field trials in 8 EU countries and supporting production upscaling before European launch in 2023.
- Université Libre de BruxellessupportingAcademic research partner in Belgium for biostimulant development.
- UCLouvainsupportingAcademic research partner for agricultural biotechnology research.
- UMonssupportingAcademic research partner for materials science and biotechnology research.
- University of LiègesupportingAcademic research partner.
- Ghent UniversitysupportingAcademic research partner in Belgium.
- Universidad de las AmericassupportingLatin American academic partner for research collaboration.
- Universidad Politécnica de MadridsupportingEuropean academic partner for agricultural research.
- Universidad de ConcepciónsupportingLatin American academic partner in Chile for agricultural biotechnology research.
- Materia NovasupportingResearch center partner for materials and biotechnology research in Belgium.
- Bio Base Europe Pilot PlantsupportingPilot scale-up facility partner for bioprocess development.
- EIT FoodsupportingEuropean Institute of Innovation and Technology food innovation community partner.
- WagralimsupportingWallonia food innovation cluster partner.
- hub.brusselssupportingBrussels regional innovation agency partner.
- InnovirissupportingBrussels regional R&D funding and innovation agency partner.
Scale indicators10 records
Recent moves11 records
Expansion highlights6 records
Fyteko competitors and assessment
Company assessmentEmerging players
- Sound Agriculture: US-based agtech company developing bio-inspired solutions for crop nutrition and stress tolerance. Emerging peer with comparable technology platform approach and focus on sustainable agriculture.
- Pivot Bio: US-based company developing microbial nitrogen-fixing biostimulants. Comparable as a venture-backed emerging player in the agricultural biologicals space, though focused on nitrogen fixation rather than abiotic stress.
Direct peers
- Biolchim: Italian manufacturer of biostimulants and specialty fertilizers. Directly comparable to Fyteko in biostimulant product category with focus on foliar and fertigation applications for global markets.
- Seipasa: Spanish biostimulant and biocontrol manufacturer focused on sustainable agriculture. Direct competitor to Fyteko with similar product positioning in plant stress tolerance.
- Tradecorp (Rovensa): Global biostimulant and crop nutrition company, part of Rovensa group. Competes directly with Fyteko across biostimulant categories for both specialty and row crops.
- Bioiberica: Spanish biotechnology company with biostimulant and biocontrol product lines for agriculture. Comparable to Fyteko in developing bio-based plant protection solutions.
- Symborg: Spanish agricultural biotechnology company developing biostimulants and biocontrol products. Comparable business model to Fyteko with focus on bio-based solutions for sustainable agriculture.
- Valagro: Italian biostimulant and crop nutrition company acquired by Syngenta in 2020. Directly competes with Fyteko in plant biostimulants for specialty and row crops, with a broader product portfolio and global distribution.
Broad incumbents
- UPL: Indian multinational agrochemical company with growing biostimulant portfolio. Broad incumbent in crop protection that competes across multiple product categories including plant health biostimulants.
- Syngenta: Global agrochemical giant (now part of Sinochem) that acquired Valagro to enter biostimulants. Represents the largest competitive threat to Fyteko with vastly superior distribution, R&D, and customer relationships.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Fyteko social profiles
Digital presenceFyteko financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fyteko leadership team
Management profileNumber of profiles
Profiles9 records
Fyteko funding detail
Funding detailFunding overview
Funding rounds3 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fyteko M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fyteko
What does Fyteko do?
Fyteko develops, manufactures, and commercializes bio-based plant biostimulants built on a proprietary Signal Molecule technology platform using hydroxycinnamic acid oligomers. Its commercial product lines comprise NURSPRAY® foliar spray biostimulants and NURSEED® seed treatment biostimulants, with VacStress® for furrow application, designed to enhance crop resilience against abiotic stresses such as drought and heat and improve yields through sustainable mechanisms.
Is Fyteko a public or private company?
Fyteko is a private company. It is classified as venture growth investor backed and is currently operating.
When was Fyteko founded?
Fyteko was founded in 2014. It employs 11 to 50 people.
Where is Fyteko based?
Fyteko is headquartered in Brussels, Belgium, in the Europe region.
How does Fyteko make money?
Three revenue lines are on record. Biostimulant Products are the primary driver. The others are herbicide Bioenhancers (Pipeline) and biopesticides (Pipeline).
Who are Fyteko's main competitors?
Emerging players on record are Sound Agriculture and Pivot Bio. Direct peers are Biolchim, Seipasa, Tradecorp (Rovensa), Bioiberica, Symborg and Valagro. Broad incumbents are UPL and Syngenta.
Does Fyteko have an API?
No public API is recorded for Fyteko.
What industry is Fyteko in?
Fyteko's product category is Agricultural Biostimulants. Its primary akta.pro industry code is AFABAEAK, Biostimulants & Plant Health Biologicals (Microbial/Non-microbial), with a secondary code of AFABAFAJ, Seed Inoculants & Biological Seed Enhancers (Rhizobia, Mycorrhizae, PGPR). Its NAICS code is 3253 and its SIC code is 2870.